Discovered accidentally on the Easter Island, rapamycin has given rise to many myths. Today, many researchers, including Mikhail Blagosklonny, claim that rapamycin extends lifespan and hampers aging-related changes through aging-independent mechanisms, meaning that this drug does not affect aging itself and more information click here.
Aging is the exponential rise of the likelihood of death due to aging. No individual has ever died because of being healthy. Age-related diseases account for the lives of millions of people each year. Other than people and animals, worm and flies are also victims of age-related deaths and learn more about Dr. Mikhail.
Diseases acts as biomarkers of aging
Age-related illnesses are key biomarkers of aging. The popular biomarkers include cardiovascular diseases, Alzheimer and Parkinson, diabetes, macular degeneration, and diabetes. Many signs of aging are not categorized as diseases since they manifest in everyone, for instance, female menopause.
Cancer and aging
Cancer is a perfect example of aging-related condition and measures that reduce the aging process, such as calorie restriction, delay cancer. Additionally, rapamycin is stronger than calorie restriction when it comes to inhibiting MTOR. It is expected that if rapamycin can prolong lifespan, it should slow down cancer. Hosts of studies back these predictions because rapamycin appeared to prolong life expectancy and delay cancer when even calorie restriction failed to do so. Rapamycin is highly reliable in drug combinations. It may reduce side effects by delaying the death of normal cells.
Blagosklonny’s efforts of developing an effective cancer therapy
Blagosklonny is a reputable scientist who works diligently to ensure every person worldwide has access to better treatment despite his or her economic status. He is mainly interested in the discipline of medical research, and he has concentrated on oncology and aging studies. Through his many studies, Blagosklonny strives to identify risk factors that predispose people above a specific age to cancer. His research continues to bring breakthroughs in the oncology field. In his capacity as a professor, researcher, and chief editor, Blagosklonny has become an iconic figure in the scientific community. He has and continues to mentor young scientists who seek to build successful careers as researchers. Blagosklonny is an author and co-author of many internationally known research papers. He mostly writes about oncology and aging and Mikhail’s lacrosse camp.
A look at Oncologist Mikhail Blagosklonny
Blagosklonny is world’s top researcher and well-decorated scientist who specializes in studying aging and cancer. He got his M.D. and doctorate at the venerated First Pavlov State Medical University of St. Petersburg. His master’s course was in the field of internal medicine while his doctorate was in the specialty of experimental medicine and cardiology. In 2002, he secured an associate professor position at the NY’s New York Medical College and his Linkedin.
Blagosklonny also took up a senior scientist post at New York’s Ordway Research Institute. He relinquished this post, following his appointment to the teaching staff of Roswell Park Cancer Institute. He conducts research that focuses on understanding Oncology and treatments that maintain the health standards of normal cells. He also studies the process of aging and effective anti-aging drugs and http://www.tandfonline.com/doi/pdf/10.4161/cbt.8.9.8899.